Publish in this journal
Journal Information
Vol. 89. Num. 1.01 July 2018
Pages 1-66
Download PDF
More article options
Vol. 89. Num. 1.01 July 2018
Pages 1-66
Spanish Association of Paediatrics
DOI: 10.1016/j.anpede.2018.01.008
The Spanish Society of Paediatric Infectious Diseases guidelines on the prevention, diagnosis and treatment of neonatal herpes simplex infections
Guía de la Sociedad Española de Infectología Pediátrica sobre prevención, diagnóstico y tratamiento de la infección neonatal por virus herpes simplex
Working Group on Neonatal Infection by Herpes Simplex Virus of the Sociedad Española de Infectología Pediátrica
This item has received
Article information
Full Text
Download PDF
Tables (7)
Table 1. Risk factors for neonatal herpes.
Table 2. Classification of the type of genital herpes based on the results of lesion swab viral detection tests and serologic tests (type-specific).
Table 3. Forms of neonatal infection by HSV.19–25
Table 4. Diagnosis and evaluation of neonatal infection by HSV.
Table 5. Recommendations for the management of recurrent disease in patients undergoing suppressive therapy with acyclovir.
Table 6. Mortality at age 1 year by form of neonatal infection by HSV.22,33,40
Table 7. Prognostic factors that predict a poor outcome of neonatal infection by HSV.
Show moreShow less

Neonatal herpes simplex virus infections are rare, but are associated with significant morbidity and mortality. Most newborns acquire herpes simplex virus infection in the peripartum period. For peripartum transmission to occur, women must be shedding the virus in their genital tracts symptomatically or asymptomatically around the time of delivery. There are evidence-based interventions in pregnancy to prevent the transmission to the newborn. Caesarean section should be performed in the presence of herpetic lesions, and antiviral prophylaxis in the last weeks of pregnancy is recommended to suppress genital tract herpes simplex virus at the time of delivery. The diagnosis and early treatment of neonatal herpes simplex virus infections require a high index of suspicion, especially in the absence of skin lesions. It is recommended to rule out herpes simplex virus infections in those newborns with mucocutaneous lesions, central nervous system involvement, or septic appearance. The prognosis of newborns with skin, eye, and/or mouth disease in the high-dose acyclovir era is very good. Antiviral treatment not only improves mortality rates in disseminated and central nervous system disease, but also improves the rates of long-term neurodevelopmental impairment in the cases of disseminated disease. Interestingly, a 6-month suppressive course of oral acyclovir following the acute infection has improved the neurodevelopmental prognosis in patients with CNS involvement.

Neonatal infection
Herpes simplex virus
Mother-to-child transmission prevention

La infección herpética neonatal es una entidad muy poco frecuente pero que se asocia a una alta morbimortalidad. La mayor parte de los neonatos afectos adquieren la infección por virus herpes simplex en el periodo periparto. Para que ocurra esta transmisión es necesaria la excreción viral genital, con o sin síntomas, alrededor del momento del parto. Existen intervenciones basadas en la evidencia para prevenir la transmisión del virus herpes simplex al recién nacido. La realización de una cesárea en presencia de lesiones herpéticas, y la disminución de la excreción viral administrando en las últimas semanas del embarazo tratamiento antiviral a gestantes con herpes genital activo, son las mejores medidas preventivas de las que se dispone. El diagnóstico y tratamiento precoz del herpes neonatal requiere de un alto índice de sospecha, sobre todo en ausencia de lesiones cutáneas. Se recomienda descartar la infección por herpes neonatal en aquellos recién nacidos con lesiones cutaneomucosas, afectación del sistema nervioso central o cuadro séptico de origen no aclarado. El pronóstico de los neonatos con enfermedad cutánea en la era del aciclovir a dosis altas es excelente. El tratamiento antiviral disminuye la mortalidad de las formas diseminadas y con afectación exclusiva del sistema nervioso central, pero también mejora el pronóstico neurológico en los casos de enfermedad diseminada. De forma notable, la introducción del tratamiento supresor con aciclovir oral durante los meses siguientes a la infección aguda ha mejorado el pronóstico neurológico en los pacientes con afectación del sistema nervioso central.

Palabras clave:
Infección neonatal
Virus herpes simplex
Prevención de la transmisión maternoinfantil


These are the options to access the full texts of the publication Anales de Pediatría (English Edition)
If you are a member of the Asociación Española de Pediatría:
Go to the members area of the website of the AEPED, ( )and login.

Next go to the journal


If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Anales de Pediatría (English Edition)

Subscribe to our Newsletter

Article options
Cookies policy
To improve our services and products, we use cookies (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.